Safety & effectiveness study to evaluate if prophylactic left atrial appendage exclusion reduces occurrence of ischemic stroke or systemic embolism in cardiac surgery patients with elevated risk of stroke and no history of atrial fibrillation
In a retrospective analysis sponsored by AtriCure, researchers found that patients who received cryoablation had a lower opioid prescription refill rate after 90 days, even among chronic opioid users.
Learn more about the study results at: https://t.co/jukkCNzHr4
Made with a tighter weave fabric, the AtriClip® FLEX-Mini™ Device is designed with polyester for secure placement and stability.
Discover AtriClip FLEX-Mini: https://t.co/BKqUgWiHVX#CardioTwitter#LAAE
Join us at EACTS Lisbon to discuss the impact of the 2024 ESC/EACTS Guidelines, which elevated surgical #Afib ablation and LAA exclusion to a Class I recommendation. Learn how to adopt these in your clinical practice for optimal patient care. Learn more: https://t.co/4lxSI2vfgg
The LeAAPS Trial is a pivotal initiative intended to evaluate the safety and effectiveness of surgical LAA exclusion to prevent stroke in patients with an elevated risk, but no history of Afib.
Learn more about the groundbreaking study: https://t.co/axe7Ec8Vdn#ClinicalTrial
Our manufacturing team is central to our mission. Whether it's on the assembly line or through welding, their exceptional work drives forward our advancements in Afib treatment and post-operative pain management.
Join us as Adam Harp, Senior Principal Model Designer, gives an exclusive behind-the-scenes look at what manufacturing at AtriCure is all about.
#MFGDay2024
If your IST symptoms are negatively affecting your quality of life, the HEAL-IST Trial is underway to evaluate the safety and effectiveness of a new hybrid ablation procedure to treat patients with symptomatic IST who are resistant or unable to tolerate medications.
Learn more at: https://okt.to/m2ndPf
In a retrospective analysis sponsored by AtriCure, researchers found that patients who received cryoablation had a lower opioid prescription refill rate after 90 days, even among chronic opioid users.
Learn more about the study results at: https://okt.to/TVlb6S
Made with a tighter weave fabric, the AtriClip® FLEX-Mini™ Device is designed with polyester for secure placement and stability.
Discover AtriClip FLEX-Mini: https://okt.to/VReBDy
Practice guidelines and quality metrics are based on compelling science. The LeAAPS Trial is a pivotal initiative intended to evaluate the safety and effectiveness of surgical LAA exclusion to prevent stroke in patients with an elevated risk, but no history of Afib.
Learn more about the groundbreaking study: https://okt.to/BFwYZ3
#ClinicalTrial#stroke#CardiacSurgery
Hey The Ohio State University students! We’re excited to join you for Diversity Career Day on October 15th. Drop by our booth to explore student opportunities and career paths in the medical device industry. Join an organization that celebrates diversity and inclusivity!
Apply early at:
https://okt.to/n8civy
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.
Click "Agree" to confirm you are a Patient or a Caregiver.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
social media channels to keep updated on the latest at AtriCure.
About the 3D Heart Education App
Duration: 00:37
AtriCure Patient Atrial Fibrillation Animation
Duration: 5:43
Sinus Rhythm Matters
Duration: 00:46
Vass’ Story with Afib and Hybrid AF Therapy
Duration: 4:49